CN102070786B - Hyaluronic acid-sodium alginate composite hydrogel and preparation method thereof - Google Patents
Hyaluronic acid-sodium alginate composite hydrogel and preparation method thereof Download PDFInfo
- Publication number
- CN102070786B CN102070786B CN2009102376051A CN200910237605A CN102070786B CN 102070786 B CN102070786 B CN 102070786B CN 2009102376051 A CN2009102376051 A CN 2009102376051A CN 200910237605 A CN200910237605 A CN 200910237605A CN 102070786 B CN102070786 B CN 102070786B
- Authority
- CN
- China
- Prior art keywords
- solution
- hyaluronic acid
- sodium
- sodium alginate
- mucinase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000661 sodium alginate Substances 0.000 title claims abstract description 50
- 229940005550 sodium alginate Drugs 0.000 title claims abstract description 50
- 239000002131 composite material Substances 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 239000000017 hydrogel Substances 0.000 title abstract description 30
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 title description 16
- 239000000243 solution Substances 0.000 claims abstract description 60
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 34
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 34
- 238000000034 method Methods 0.000 claims abstract description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 238000003756 stirring Methods 0.000 claims abstract description 21
- 108010003272 Hyaluronate lyase Proteins 0.000 claims abstract description 17
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 12
- 239000012190 activator Substances 0.000 claims abstract description 9
- 239000008351 acetate buffer Substances 0.000 claims description 5
- 150000001718 carbodiimides Chemical class 0.000 claims description 4
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 claims description 2
- IBVAQQYNSHJXBV-UHFFFAOYSA-N adipic acid dihydrazide Chemical compound NNC(=O)CCCCC(=O)NN IBVAQQYNSHJXBV-UHFFFAOYSA-N 0.000 claims description 2
- 239000007979 citrate buffer Substances 0.000 claims description 2
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 claims 1
- 239000008363 phosphate buffer Substances 0.000 claims 1
- -1 polyoxyethylene Polymers 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 239000000499 gel Substances 0.000 abstract description 50
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract description 38
- 229920002674 hyaluronan Polymers 0.000 abstract description 38
- 229960003160 hyaluronic acid Drugs 0.000 abstract description 38
- 239000007853 buffer solution Substances 0.000 abstract description 12
- 239000003431 cross linking reagent Substances 0.000 abstract description 11
- 102000001974 Hyaluronidases Human genes 0.000 abstract description 10
- 229960002773 hyaluronidase Drugs 0.000 abstract description 10
- 238000012986 modification Methods 0.000 abstract description 4
- 230000004048 modification Effects 0.000 abstract description 4
- 239000000872 buffer Substances 0.000 abstract 1
- 238000005406 washing Methods 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 15
- 238000012360 testing method Methods 0.000 description 12
- 239000000126 substance Substances 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 7
- 239000008367 deionised water Substances 0.000 description 6
- 229910021641 deionized water Inorganic materials 0.000 description 6
- 230000015556 catabolic process Effects 0.000 description 5
- 238000006731 degradation reaction Methods 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000013467 fragmentation Methods 0.000 description 3
- 238000006062 fragmentation reaction Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 238000010979 pH adjustment Methods 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 238000004626 scanning electron microscopy Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 238000009777 vacuum freeze-drying Methods 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 238000004566 IR spectroscopy Methods 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- AEMOLEFTQBMNLQ-AZLKCVHYSA-N (2r,3s,4s,5s,6r)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-AZLKCVHYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-SYJWYVCOSA-N (2s,3s,4s,5s,6r)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-SYJWYVCOSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 239000002407 tissue scaffold Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Cosmetics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
本发明公开了一种透明质酸和海藻酸钠复合水凝胶及其制备方法。该复合水凝胶是按照包括下述步骤的方法制备得到的:1)将透明质酸和海藻酸钠溶于水中,得到溶液1,2)将交联剂加入所述溶液1中,并用缓冲溶液调节pH值为4.0-5.5,得到溶液2;3)向所述溶液2中加入羧基激活剂并搅拌,搅拌过程中用缓冲溶液调控所述溶液2的pH值在2.0-5.5直至形成凝胶,即得到透明质酸和海藻酸钠复合水凝胶。本发明为透明质酸的改性提供了新的途径,用本发明方法制备的复合改性物具有较高的机械性能、抗透明质酸酶降解能力、生物相容性等优点,在外科手术、组织工程方面有着潜在的用途。The invention discloses a composite hydrogel of hyaluronic acid and sodium alginate and a preparation method thereof. The composite hydrogel is prepared according to a method comprising the following steps: 1) dissolving hyaluronic acid and sodium alginate in water to obtain solution 1, 2) adding a cross-linking agent to said solution 1, and using a buffer adjusting the pH value of the solution to 4.0-5.5 to obtain solution 2; 3) adding a carboxyl activator to the solution 2 and stirring, using a buffer solution to control the pH value of the solution 2 at 2.0-5.5 until a gel is formed during the stirring process , to obtain hyaluronic acid and sodium alginate composite hydrogel. The present invention provides a new approach for the modification of hyaluronic acid, and the composite modified product prepared by the method of the present invention has the advantages of high mechanical properties, hyaluronidase resistance, biocompatibility, etc. , Tissue engineering has potential applications.
Description
技术领域 technical field
本发明涉及一种透明质酸-海藻酸钠复合水凝胶及其制备方法。The invention relates to a hyaluronic acid-sodium alginate composite hydrogel and a preparation method thereof.
背景技术 Background technique
透明质酸(hyaluronic acid,HA)是一种线性、无支链酸性粘多糖,由N-乙酰氨基葡萄糖和D-葡萄糖醛酸反复交替组成,是一种价值很高的医药、化妆品原料。HA具有良好的亲水性、生物相容性和保湿功能,广泛应用于化妆品中,被誉为天然保湿因子。HA还具有很好的生物相容性,在体内不产生排异反应。由于HA独特的流变学性质、润滑性和生物相容性等物理化学性质,HA可作为弹性材料应用于眼外科手术,治疗骨关节疾病,并具有促进伤口愈合和一定抗癌效果。HA在药物缓释、术后防粘连和组织工程中也具有重要作用。Hyaluronic acid (HA) is a linear, unbranched acidic mucopolysaccharide composed of N-acetylglucosamine and D-glucuronic acid alternately. It is a valuable raw material for medicine and cosmetics. HA has good hydrophilicity, biocompatibility and moisturizing function. It is widely used in cosmetics and is known as a natural moisturizing factor. HA also has good biocompatibility and does not produce rejection in the body. Due to HA's unique rheological properties, lubricity and biocompatibility and other physical and chemical properties, HA can be used as an elastic material in eye surgery, treatment of bone and joint diseases, and has the effect of promoting wound healing and certain anticancer effects. HA also plays an important role in drug sustained release, postoperative anti-adhesion and tissue engineering.
但是,机械性质较差、在体内易被透明质酸酶快速降解等缺陷限制了透明质酸在临床应用。为了改善HA的物理、化学稳定性,同时保持其天然的生物相容性、生物可降解性和体内无排异的特性,人们采用多种途径对其羟基和羧基进行改性修饰。化学改性方法包括交联、接枝、酯化和复合改性等。目前,由于复合改性往往能够保持两种原料的最初的特性而受到人们的关注。对于复合改性而言,许多大分子物质通过羧基或羟基与HA的羧基形成交联。成功复合交联的物质包括羧甲基纤维素钠、胶原质、明胶、聚乳酸、壳聚糖等。海藻酸钠(sodium alginate,简称SAL)是一种由α-L-古罗糖醛酸和β-D-甘露糖醛酸通过1,4-糖苷键连接而成的酸性粘多糖,广泛应用于食品加工、医药领域,包括药物缓释载体、细胞培养等。SAL具有良好的生物相容性,一旦形成凝胶后,便具有较好的机械性质。SAL与其他多糖,如壳聚糖、硫酸软骨素等的复合物已见诸报道,也有人对SAL-HA的复合物进行了流变学的考察,但这种复合物仅是两种高分子物质的混合液。However, defects such as poor mechanical properties and rapid degradation by hyaluronidase in vivo limit the clinical application of hyaluronic acid. In order to improve the physical and chemical stability of HA while maintaining its natural biocompatibility, biodegradability and non-rejection characteristics in vivo, people have used various methods to modify its hydroxyl and carboxyl groups. Chemical modification methods include cross-linking, grafting, esterification and composite modification. At present, because compound modification can often maintain the original characteristics of the two raw materials, it has attracted people's attention. For composite modification, many macromolecular substances form cross-links with carboxyl groups of HA through carboxyl or hydroxyl groups. Substances successfully compounded and cross-linked include sodium carboxymethyl cellulose, collagen, gelatin, polylactic acid, chitosan, etc. Sodium alginate (SAL for short) is an acidic mucopolysaccharide composed of α-L-guluronic acid and β-D-mannuronic acid connected by 1,4-glycosidic bonds, and is widely used in Food processing and pharmaceutical fields, including drug slow-release carriers, cell culture, etc. SAL has good biocompatibility and, once gelled, has good mechanical properties. Compounds of SAL and other polysaccharides, such as chitosan, chondroitin sulfate, etc., have been reported, and some people have conducted rheological investigations on the compound of SAL-HA, but this compound is only two kinds of polymers. mixture of substances.
发明内容 Contents of the invention
本发明的目的是提供一种透明质酸-海藻酸钠复合水凝胶及其制备方法。The object of the present invention is to provide a hyaluronic acid-sodium alginate composite hydrogel and a preparation method thereof.
本发明所提供的透明质酸(HA)和海藻酸钠(SAL)复合水凝胶是按照包括下述步骤的方法制备的:Hyaluronic acid (HA) and sodium alginate (SAL) composite hydrogel provided by the present invention are prepared according to the method comprising the following steps:
1)将透明质酸和海藻酸钠溶于水中,得到溶液1,1) Dissolving hyaluronic acid and sodium alginate in water to obtain solution 1,
2)将交联剂加入所述溶液1中,并用缓冲溶液调节pH值为4.0-5.5,得到溶液2;2) adding a cross-linking agent into the solution 1, and adjusting the pH value to 4.0-5.5 with a buffer solution to obtain a solution 2;
3)向所述溶液2中加入羧基激活剂并搅拌,搅拌过程中用缓冲溶液调节所述溶液2的pH值在2.0-5.5直至形成凝胶,即得到透明质酸和海藻酸钠复合水凝胶。3) Add a carboxyl activator to the solution 2 and stir. During the stirring process, adjust the pH value of the solution 2 to 2.0-5.5 with a buffer solution until a gel is formed, that is, to obtain a composite hydrogel of hyaluronic acid and sodium alginate glue.
上述溶液1中,透明质酸和海藻酸钠的质量比可为1∶4-4∶1,优选质量比为1∶2。溶液1中,透明质酸和海藻酸钠的浓度之和可为0.5-1.5g/100ml,优选为1.0g/100ml。In the above solution 1, the mass ratio of hyaluronic acid and sodium alginate can be 1:4-4:1, preferably 1:2. In solution 1, the sum of the concentrations of hyaluronic acid and sodium alginate may be 0.5-1.5g/100ml, preferably 1.0g/100ml.
上述步骤2)中所述交联剂可选自下述至少一种:己二酸二酰肼(ADH),聚乙二醇(PEG),戊二醛和二乙烯基砜(GTA),优选为己二酸二酰肼(ADH);所述交联剂的加入量与所述溶液1的配比可为0.1g-1.0g∶100mL,优选为0.52g∶100mL。The cross-linking agent described in the above step 2) can be selected from at least one of the following: adipate dihydrazide (ADH), polyethylene glycol (PEG), glutaraldehyde and divinyl sulfone (GTA), preferably It is adipic acid dihydrazide (ADH); the ratio of the added amount of the crosslinking agent to the solution 1 can be 0.1g-1.0g:100mL, preferably 0.52g:100mL.
步骤3)中所述羧基激活剂可选自下述至少一种:碳化二亚胺(EDC),N-羟基琥珀酰亚胺(NHS)和N,N,N″,N″一四甲基乙二胺(TEMED),优选为碳化二亚胺;所述碳化亚胺的添加量与所述溶液2的配比可为10mmol-100mmol∶1L,优选为50mmol∶1L。The carboxyl activator in step 3) can be selected from at least one of the following: carbodiimide (EDC), N-hydroxysuccinimide (NHS) and N, N, N ", N "-tetramethyl Ethylenediamine (TEMED), preferably carbodiimide; the ratio of the added amount of the carboimide to the solution 2 may be 10mmol-100mmol:1L, preferably 50mmol:1L.
步骤3)中所述搅拌可在15℃-40℃条件下进行,优选为20℃-30℃;所述搅拌过程中需用缓冲溶液调控溶液2的pH值为2.0-5.5,优选pH值为4.75。搅拌时,搅拌的转速应不宜过快,避免导致形成凝胶后变稀。The stirring in step 3) can be carried out at 15°C-40°C, preferably 20°C-30°C; during the stirring process, a buffer solution is required to control the pH value of solution 2 to 2.0-5.5, preferably the pH value is 4.75. When stirring, the stirring speed should not be too fast, so as not to cause the gel to become thinner.
上述步骤2)和步骤3)中所用的缓冲溶液相同,所述缓冲溶液可选自下述任意一种:磷酸盐缓冲溶液,柠檬酸盐缓冲溶液和醋酸盐缓冲溶液;所述缓冲溶液的浓度可为0.01-0.5mol/L,pH值为2.0-4.5,优选为醋酸盐缓冲溶液,最优选浓度为0.1mol/L,pH值为3.6的醋酸盐缓冲溶液。Above-mentioned step 2) and the buffer solution used in step 3) are identical, and described buffer solution can be selected from following any one: phosphate buffer solution, citrate buffer solution and acetate buffer solution; The concentration can be 0.01-0.5 mol/L, the pH value is 2.0-4.5, preferably acetate buffer solution, the most preferred concentration is 0.1 mol/L, the pH value is 3.6 acetate buffer solution.
本发明的方法还包括对步骤3)得到的透明质酸和海藻酸钠复合水凝胶进行洗涤的步骤。洗涤次数不应少于5次,洗涤时慢慢翻转凝胶,以使残余反应杂质溶于水中而去除。The method of the present invention also includes the step of washing the hyaluronic acid and sodium alginate composite hydrogel obtained in step 3). The number of washings should not be less than 5 times, and the gel should be turned over slowly during washing, so that the residual reaction impurities can be dissolved in water and removed.
本发明所用的透明质酸的分子量可为5.0×105Da-2.1×106Da,优选分子量为1.5×106Da;所用的海藻酸钠粉末的粒度为50目-300目,优选为200目。The molecular weight of the hyaluronic acid used in the present invention can be 5.0×10 5 Da-2.1×10 6 Da, preferably 1.5×10 6 Da; the particle size of the sodium alginate powder used is 50 mesh-300 mesh, preferably 200 mesh head.
本发明是在羧基活化剂存在下,由分子结构中具有两个或两个以上氨基的高聚物或低聚物(交联剂)与透明质酸、海藻酸钠进行酰胺化反应交联而制得硬度、粘弹性较好的透明质酸-海藻酸钠复合交联物。获得的复合交联水凝胶具备HA和SAL的双重优点,一方面,抗酶降解的能力得到提高,另一方面,水凝胶的机械性质和质构特征得到改善。复合交联水凝胶的物理化学性质改善后,具有作为真皮填充物和组织支架材料的潜在用途而用于外科手术、组织工程领域。In the present invention, in the presence of a carboxyl activator, the polymer or oligomer (cross-linking agent) with two or more amino groups in the molecular structure undergoes amidation reaction cross-linking with hyaluronic acid and sodium alginate. A hyaluronic acid-sodium alginate composite cross-linked product with good hardness and viscoelasticity is obtained. The obtained composite cross-linked hydrogel has the dual advantages of HA and SAL. On the one hand, the ability to resist enzymatic degradation is improved, and on the other hand, the mechanical properties and textural characteristics of the hydrogel are improved. After the physical and chemical properties of the composite cross-linked hydrogel are improved, it has the potential use as a dermal filler and tissue scaffold material in the fields of surgery and tissue engineering.
附图说明 Description of drawings
图1为本发明制备透明质酸-海藻酸钠复合水凝胶的工艺流程图。Fig. 1 is a process flow chart of the present invention for preparing hyaluronic acid-sodium alginate composite hydrogel.
图2为实施例1制备的透明质酸-海藻酸钠复合水凝胶的红外光谱图。Fig. 2 is the infrared spectrogram of the hyaluronic acid-sodium alginate composite hydrogel prepared in Example 1.
具体实施方式 Detailed ways
下面通过具体实施例对本发明的方法进行说明,但本发明并不局限于此。The method of the present invention will be described below through specific examples, but the present invention is not limited thereto.
下述实施例中所述实验方法,如无特殊说明,均为常规方法;所述试剂和材料,如无特殊说明,均可从商业途径获得。The experimental methods described in the following examples, unless otherwise specified, are conventional methods; the reagents and materials, unless otherwise specified, can be obtained from commercial sources.
实施例1、透明质酸-海藻酸钠水凝胶的制备及其理化特性验证Example 1. Preparation of hyaluronic acid-sodium alginate hydrogel and verification of its physical and chemical properties
按照图1所示的工艺流程图制备透明质酸-海藻酸钠水凝胶,具体步骤如下:Prepare hyaluronic acid-sodium alginate hydrogel according to the process flow diagram shown in Figure 1, and the specific steps are as follows:
①多糖溶解:分子量为1.5×106Da的透明质酸(山东福瑞达生物化工有限公司)和海藻酸钠(粒径为200目筛,10mg/ml的水溶液,在25℃时其粘度为205mPa·s,青岛晶岩生物科技有限公司)以1∶2的比例(质量比)溶于水中,令其总浓度为1.0%(g/100ml),得到溶液1。①Polysaccharide dissolution: hyaluronic acid (Shandong Freda Biochemical Co., Ltd.) with a molecular weight of 1.5×10 6 Da and sodium alginate (a particle size of 200 mesh sieve, 10 mg/ml aqueous solution, the viscosity at 25°C is 205mPa·s, Qingdao Jingyan Biotechnology Co., Ltd.) was dissolved in water at a ratio (mass ratio) of 1:2, so that its total concentration was 1.0% (g/100ml), and solution 1 was obtained.
②添加交联剂并调节溶液pH:待步骤①中的多糖完全溶解后,将交联剂ADH(北京金源化学集团有限公司)以0.52g∶100ml的配比加入所述溶液1中,混合均匀。并对上述混合溶液进行pH调整,用0.1mol/L的HAc-NaAc缓冲液(pH 3.6)调整pH至4.75,得到溶液2。②Add a cross-linking agent and adjust the pH of the solution: After the polysaccharide in step ① is completely dissolved, add the cross-linking agent ADH (Beijing Jinyuan Chemical Group Co., Ltd.) into the solution 1 at a ratio of 0.52g:100ml, mix uniform. And carry out pH adjustment to above-mentioned mixed solution, adjust pH to 4.75 with the HAc-NaAc buffer solution (pH 3.6) of 0.1mol/L, obtain solution 2.
③添加羧基激活剂:向溶液2加入EDC(上海共价化学有限公司),使其EDC浓度达到50mmol/L。③Add carboxyl activator: add EDC (Shanghai Covalent Chemical Co., Ltd.) to Solution 2 to make the EDC concentration reach 50mmol/L.
④搅拌进行反应并控制pH:对步骤③中的反应液进行搅拌并控制pH,加入EDC的同时即开始进行搅拌,搅拌速度不宜过快,避免形成的凝胶剪切变稀。在室温下搅拌4h,反应过程中,通过滴加0.1mol/L的HAc-NaAc缓冲液使反应液的pH值保持在4.75,得到透明质酸和海藻酸钠复合水凝胶。④Stir to react and control pH: Stir the reaction solution in step ③ and control pH, and start stirring at the same time as EDC is added. The stirring speed should not be too fast to avoid shear thinning of the formed gel. Stirring at room temperature for 4 hours, during the reaction, the pH value of the reaction solution was kept at 4.75 by dropwise adding 0.1 mol/L HAc-NaAc buffer solution to obtain a composite hydrogel of hyaluronic acid and sodium alginate.
⑤凝胶洗涤:对步骤④形成的复合水凝胶,用去离子水反复洗涤,洗涤次数应不少于5次,每次洗涤20分钟以上,洗涤时慢慢翻转凝胶,使残余反应杂质溶于水中而去除。⑤ Gel washing: For the composite hydrogel formed in step ④, wash repeatedly with deionized water. The number of washings should not be less than 5 times, and each time the washing time should be more than 20 minutes. Slowly turn the gel when washing to make the residual reaction impurities Dissolved in water and removed.
⑥凝胶保存:对步骤⑤洗涤后的凝胶在4℃下保存。⑥ Gel storage: Store the gel after washing in step ⑤ at 4°C.
按照上述方法制得的透明质酸-海藻酸钠复合水凝胶为无色,具有一定的硬度和粘弹性。The hyaluronic acid-sodium alginate composite hydrogel prepared according to the above method is colorless and has certain hardness and viscoelasticity.
对透明质酸一海藻酸钠复合水凝胶的特性进行测定:1、采用FT-IR光谱仪(Nicolet Nexus,Thermo Electron,USA)测定是否形成共价键;2、采用扫描电镜(Hitachi SEM-2500,Japan)观察形成凝胶的微结构;3、采用质构仪对凝胶的质构特征进行测定(pre test speed 2.0mm/s,test speed 0.8mm/s,post test speed 2.0mm/s,rupture test distance 4.0%,distance 50%,temperature 25℃.)。The characteristics of the hyaluronic acid-sodium alginate composite hydrogel were measured: 1, using FT-IR spectrometer (Nicolet Nexus, Thermo Electron, USA) to determine whether a covalent bond was formed; 2, using a scanning electron microscope (Hitachi SEM-2500 , Japan) to observe the microstructure of the gel; 3. Use a texture analyzer to measure the texture characteristics of the gel (pre test speed 2.0mm/s, test speed 0.8mm/s, post test speed 2.0mm/s, rupture test distance 4.0%, distance 50%, temperature 25°C.).
红外光谱图见图2,测定结果表明凝胶形成了新的共价键,透明质酸和海藻酸钠通过己二酸二酰肼(ADH)交联在一起。扫描电镜表明,凝胶中形成较均匀而孔径适宜的网状结构。质构仪(Cns-Farnell,Britain)测得凝胶硬度为357.06g,碎裂度为253.56g,弹性为0.961。The infrared spectrogram is shown in Figure 2. The measurement results show that the gel has formed a new covalent bond, and hyaluronic acid and sodium alginate are cross-linked by adipate dihydrazide (ADH). Scanning electron microscopy showed that a relatively uniform network structure with suitable pore size was formed in the gel. The gel hardness measured by a texture analyzer (Cns-Farnell, Britain) was 357.06g, the fragmentation degree was 253.56g, and the elasticity was 0.961.
溶胀试验:Swelling test:
真空冻干后的凝胶,称重后置于去离子水中12h,用滤纸去除表面的水后,称重,结果表明,凝胶吸水可达自身重的40-50倍。The gel after vacuum freeze-drying was weighed and placed in deionized water for 12 hours. After removing the water on the surface with filter paper, the gel was weighed. The results showed that the gel could absorb water up to 40-50 times its own weight.
抗酶降解试验:Anti-enzyme degradation test:
凝胶样品置于10ml酶活力为10U/ml的透明质酸酶液中,每间隔3h从中取1ml上清液进行测定,然后补充1ml新配制的透明质酸酶液至反应体系中。测定方法如下:5mL浓H2SO4置于试管中并冷却至4℃,1mL样液或标准液小心地置于浓H2SO4层之上,开始轻轻振摇,然后剧烈振摇,并使之在冰浴中不断冷却,接下来将试管在沸腾的蒸馏水中加热10min,然后冷却至室温,加入0.2mL咔唑试液,再次摇匀,并在沸水浴中加热15min,冷却至室温,将反应液倒入1cm比色皿中,在530nm下测定吸光度(A530)。通过标准曲线测定溶液中透明质酸含量。根据下列公式计算凝胶被透明质酸酶分解的程度:The gel sample was placed in 10ml of hyaluronidase solution with an enzyme activity of 10U/ml, and 1ml of the supernatant was taken every 3 hours for measurement, and then 1ml of freshly prepared hyaluronidase solution was added to the reaction system. The determination method is as follows: 5mL of concentrated H2SO4 is placed in a test tube and cooled to 4°C, 1mL of sample solution or standard solution is carefully placed on top of the concentrated H2SO4 layer, shaken gently at first, then vigorously, And make it cool continuously in ice bath, then heat the test tube in boiling distilled water for 10min, then cool to room temperature, add 0.2mL carbazole test solution, shake well again, and heat in boiling water bath for 15min, cool to room temperature , Pour the reaction solution into a 1cm cuvette, and measure the absorbance (A530) at 530nm. The content of hyaluronic acid in the solution was determined by a standard curve. Calculate the degree of degradation of the gel by hyaluronidase according to the following formula:
Wi=CiV+∑Ci-1Vs Wi=C i V+∑C i-1 V s
其中,Ci和Ci-1为凝胶在i和i-1时刻被分解下来的HA浓度(mg/ml),V为酶液总体积(10ml),Vs为每次取出的样品体积(1ml)。Among them, C i and C i-1 are the HA concentration (mg/ml) that the gel is decomposed at time i and i-1, V is the total volume of enzyme solution (10ml), and Vs is the sample volume taken out each time ( 1ml).
结果表明,随着处理时间的延长,凝胶逐渐被透明质酸酶分解,在第9h时,几乎被分解完全,而对照组的透明质酸凝胶,在3h后即被分解完全。The results showed that with the prolongation of treatment time, the gel was gradually decomposed by hyaluronidase, and it was almost completely decomposed at 9 hours, while the hyaluronic acid gel in the control group was completely decomposed after 3 hours.
实施例2、透明质酸-海藻酸钠水凝胶的制备及其理化特性验证Example 2. Preparation of hyaluronic acid-sodium alginate hydrogel and verification of its physical and chemical properties
按照图1所示的工艺流程图制备透明质酸-海藻酸钠水凝胶,具体步骤如下:Prepare hyaluronic acid-sodium alginate hydrogel according to the process flow diagram shown in Figure 1, and the specific steps are as follows:
①多糖溶解:分子量为5.0×105Da的透明质酸(山东福瑞达生物化工有限公司)和海藻酸钠(粒径为50目筛,10mg/ml的水溶液,在25℃时其粘度为100mPa·s,青岛晶岩生物科技有限公司)以1∶4的比例(质量比)溶于水中,令其总浓度为0.5%(g/100ml),得到溶液1。①Polysaccharide dissolution: hyaluronic acid (Shandong Freda Biochemical Co., Ltd.) with a molecular weight of 5.0×10 5 Da and sodium alginate (a particle size of 50 mesh sieve, 10 mg/ml aqueous solution, the viscosity at 25 °C is 100mPa·s, Qingdao Jingyan Biotechnology Co., Ltd.) was dissolved in water at a ratio (mass ratio) of 1:4 so that its total concentration was 0.5% (g/100ml) to obtain solution 1.
②添加交联剂并调节溶液pH:待步骤①中的多糖完全溶解后,将交联剂ADH(北京金源化学集团有限公司)以0.1g∶100ml的配比加入所述溶液1中,混合均匀。并对上述混合溶液进行pH调整,用0.1mol/L的HAc-NaAc缓冲液(pH 3.6)调整pH至4.75,得到溶液2。②Add a cross-linking agent and adjust the pH of the solution: After the polysaccharide in step ① is completely dissolved, add the cross-linking agent ADH (Beijing Jinyuan Chemical Group Co., Ltd.) into the solution 1 at a ratio of 0.1g:100ml, mix uniform. And carry out pH adjustment to above-mentioned mixed solution, adjust pH to 4.75 with the HAc-NaAc buffer solution (pH 3.6) of 0.1mol/L, obtain solution 2.
③添加羧基激活剂:向溶液2加入EDC(上海共价化学有限公司),使其EDC浓度达到10mmol/L。③Add carboxyl activator: add EDC (Shanghai Covalent Chemical Co., Ltd.) to solution 2 to make the EDC concentration reach 10mmol/L.
④搅拌进行反应并控制pH:对步骤③中的反应液进行搅拌并控制pH,加入EDC的同时即开始进行搅拌,搅拌速度不宜过快,避免形成的凝胶剪切变稀。在室温下搅拌4h,反应过程中,通过滴加0.1mol/L的HAc-NaAc缓冲液使反应液的pH值保持在4.75,得到透明质酸和海藻酸钠复合水凝胶。④Stir to react and control pH: Stir the reaction solution in step ③ and control pH, and start stirring at the same time as EDC is added. The stirring speed should not be too fast to avoid shear thinning of the formed gel. Stirring at room temperature for 4 hours, during the reaction, the pH value of the reaction solution was kept at 4.75 by dropwise adding 0.1 mol/L HAc-NaAc buffer solution to obtain a composite hydrogel of hyaluronic acid and sodium alginate.
⑤凝胶洗涤:对步骤④形成的复合水凝胶,用去离子水反复洗涤,洗涤次数应不少于5次,每次洗涤20分钟以上,洗涤时慢慢翻转凝胶,使残余反应杂质溶于水中而去除。⑤ Gel washing: For the composite hydrogel formed in step ④, wash repeatedly with deionized water. The number of washings should not be less than 5 times, and each time the washing time should be more than 20 minutes. Slowly turn the gel when washing to make the residual reaction impurities Dissolved in water and removed.
⑥凝胶保存:对步骤⑤洗涤后的凝胶在4℃下保存。⑥ Gel storage: Store the gel after washing in step ⑤ at 4°C.
按照上述方法制得的透明质酸-海藻酸钠复合水凝胶为无色,具有一定的硬度和粘弹性。The hyaluronic acid-sodium alginate composite hydrogel prepared according to the above method is colorless and has certain hardness and viscoelasticity.
红外光谱测定表明,凝胶形成了新的共价键,透明质酸和海藻酸钠通过己二酸二酰肼(ADH)交联在一起。扫描电镜表明,凝胶中形成较均匀而孔径适宜的网状结构。质构仪(Cns-Farnell,Britain)测得凝胶硬度为71.02g,碎裂度为66.89g,弹性为0.97。Infrared spectroscopy showed that the gel formed new covalent bonds, and hyaluronic acid and sodium alginate were cross-linked by adipate dihydrazide (ADH). Scanning electron microscopy showed that a relatively uniform network structure with suitable pore size was formed in the gel. The gel hardness measured by a texture analyzer (Cns-Farnell, Britain) was 71.02g, the fragmentation degree was 66.89g, and the elasticity was 0.97.
溶胀试验:Swelling test:
真空冻干后的凝胶,称重后置于去离子水中12h,用滤纸去除表面的水后,称重,结果表明,凝胶吸水可达自身重的55倍。The gel after vacuum freeze-drying was weighed and placed in deionized water for 12 hours. After removing the water on the surface with filter paper, the gel was weighed. The results showed that the gel could absorb water up to 55 times its own weight.
抗酶降解试验:Anti-enzyme degradation test:
凝胶样品置于10ml酶活力为10U/ml的透明质酸酶液中,每间隔3h从中取1ml上清液进行测定。The gel sample was placed in 10 ml of hyaluronidase solution with an enzyme activity of 10 U/ml, and 1 ml of supernatant was taken from it every 3 hours for determination.
结果表明,随着处理时间的延长,凝胶逐渐被透明质酸酶分解,在第6h时,几乎被分解完全,而对照组的透明质酸凝胶,在3h后即被分解完全。The results showed that with the prolongation of treatment time, the gel was gradually decomposed by hyaluronidase, and it was almost completely decomposed at 6 hours, while the hyaluronic acid gel in the control group was completely decomposed after 3 hours.
实施例3、透明质酸-海藻酸钠水凝胶的制备及其理化特性验证Example 3. Preparation of hyaluronic acid-sodium alginate hydrogel and verification of its physical and chemical properties
按照图1所示的工艺流程图制备透明质酸-海藻酸钠水凝胶,具体步骤如下:Prepare hyaluronic acid-sodium alginate hydrogel according to the process flow diagram shown in Figure 1, and the specific steps are as follows:
①多糖溶解:分子量为2.1×106Da的透明质酸(山东福瑞达生物化工有限公司)和海藻酸钠(粒径为300目筛,10mg/ml的水溶液,在25℃时其粘度为300mPa·s,青岛晶岩生物科技有限公司)以4∶1的比例(质量比)溶于水中,令其总浓度为1.5%(g/100ml),得到溶液1。①Polysaccharide dissolution: hyaluronic acid (Shandong Freda Biochemical Co., Ltd.) with a molecular weight of 2.1×10 6 Da and sodium alginate (a particle size of 300 mesh sieve, 10 mg/ml aqueous solution, the viscosity at 25°C is 300mPa·s, Qingdao Jingyan Biotechnology Co., Ltd.) was dissolved in water at a ratio (mass ratio) of 4:1 so that its total concentration was 1.5% (g/100ml) to obtain solution 1.
②添加交联剂并调节溶液pH:待步骤①中的多糖完全溶解后,将交联剂ADH(北京金源化学集团有限公司)以1.0g∶100ml的配比加入所述溶液1中,混合均匀。并对上述混合溶液进行pH调整,用0.1mol/L的HAc-NaAc缓冲液(pH 3.6)调整pH至4.75,得到溶液2。②Add a cross-linking agent and adjust the pH of the solution: After the polysaccharide in step ① is completely dissolved, add the cross-linking agent ADH (Beijing Jinyuan Chemical Group Co., Ltd.) into the solution 1 at a ratio of 1.0g:100ml, mix uniform. And carry out pH adjustment to above-mentioned mixed solution, adjust pH to 4.75 with the HAc-NaAc buffer solution (pH 3.6) of 0.1mol/L, obtain solution 2.
③添加羧基激活剂:向溶液2加入EDC(上海共价化学有限公司),使其EDC浓度达到100mmol/L。③Add carboxyl activator: add EDC (Shanghai Covalent Chemical Co., Ltd.) to Solution 2 to make the EDC concentration reach 100mmol/L.
④搅拌进行反应并控制pH:对步骤③中的反应液进行搅拌并控制pH,加入EDC的同时即开始进行搅拌,搅拌速度不宜过快,避免形成的凝胶剪切变稀。在室温下搅拌4h,反应过程中,通过滴加0.1mol/L的HAc-NaAc缓冲液使反应液的pH值保持在4.75,得到透明质酸和海藻酸钠复合水凝胶。④Stir to react and control pH: Stir the reaction solution in step ③ and control pH, and start stirring at the same time as EDC is added. The stirring speed should not be too fast to avoid shear thinning of the formed gel. Stirring at room temperature for 4 hours, during the reaction, the pH value of the reaction solution was kept at 4.75 by dropwise adding 0.1 mol/L HAc-NaAc buffer solution to obtain a composite hydrogel of hyaluronic acid and sodium alginate.
⑤凝胶洗涤:对步骤④形成的复合水凝胶,用去离子水反复洗涤,洗涤次数应不少于5次,每次洗涤20分钟以上,洗涤时慢慢翻转凝胶,使残余反应杂质溶于水中而去除。⑤ Gel washing: For the composite hydrogel formed in step ④, wash repeatedly with deionized water. The number of washings should not be less than 5 times, and each time the washing time should be more than 20 minutes. Slowly turn the gel when washing to make the residual reaction impurities Dissolved in water and removed.
⑥凝胶保存:对步骤⑤洗涤后的凝胶在4℃下保存。⑥ Gel storage: Store the gel after washing in step ⑤ at 4°C.
按照上述方法制得的透明质酸-海藻酸钠复合水凝胶为无色,具有一定的硬度和粘弹性。The hyaluronic acid-sodium alginate composite hydrogel prepared according to the above method is colorless and has certain hardness and viscoelasticity.
红外光谱测定表明,凝胶形成了新的共价键,透明质酸和海藻酸钠通过己二酸二酰肼(ADH)交联在一起。扫描电镜表明,凝胶中形成较均匀而孔径适宜的网状结构。质构仪(Cns-Farnell,Britain)测得凝胶硬度为209.50g,碎裂度为190.28g,弹性为1.14。Infrared spectroscopy showed that the gel formed new covalent bonds, and hyaluronic acid and sodium alginate were cross-linked by adipate dihydrazide (ADH). Scanning electron microscopy showed that a relatively uniform network structure with suitable pore size was formed in the gel. The gel hardness measured by a texture analyzer (Cns-Farnell, Britain) was 209.50g, the fragmentation degree was 190.28g, and the elasticity was 1.14.
溶胀试验:Swelling test:
真空冻干后的凝胶,称重后置于去离子水中12h,用滤纸去除表面的水后,称重,结果表明,凝胶吸水可达自身重的20倍。The gel after vacuum freeze-drying was weighed and placed in deionized water for 12 hours. After removing the water on the surface with filter paper, the gel was weighed. The results showed that the gel could absorb water up to 20 times its own weight.
抗酶降解试验:Anti-enzyme degradation test:
凝胶样品置于10ml酶活力为10U/ml的透明质酸酶液中,每间隔3h从中取1ml上清液进行测定。The gel sample was placed in 10 ml of hyaluronidase solution with an enzyme activity of 10 U/ml, and 1 ml of supernatant was taken from it every 3 hours for determination.
结果表明,随着处理时间的延长,凝胶逐渐被透明质酸酶分解,在第8h时,几乎被分解完全,而对照组的透明质酸凝胶,在3h后即被分解完全。The results showed that with the prolongation of treatment time, the gel was gradually decomposed by hyaluronidase, and it was almost completely decomposed at 8 hours, while the hyaluronic acid gel in the control group was completely decomposed after 3 hours.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102376051A CN102070786B (en) | 2009-11-19 | 2009-11-19 | Hyaluronic acid-sodium alginate composite hydrogel and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102376051A CN102070786B (en) | 2009-11-19 | 2009-11-19 | Hyaluronic acid-sodium alginate composite hydrogel and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102070786A CN102070786A (en) | 2011-05-25 |
CN102070786B true CN102070786B (en) | 2012-05-30 |
Family
ID=44029558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009102376051A Expired - Fee Related CN102070786B (en) | 2009-11-19 | 2009-11-19 | Hyaluronic acid-sodium alginate composite hydrogel and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102070786B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102409731B1 (en) | 2020-04-03 | 2022-06-15 | 한양대학교 산학협력단 | Dual cross-linked self-healing hydrogel |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102391537B (en) * | 2011-07-15 | 2013-06-05 | 厦门大学 | Multilayer aquagel, and preparation method and application thereof |
CN102532564B (en) * | 2012-01-16 | 2013-09-25 | 孙珊 | Hydrogel and preparation method thereof |
CN102657871B (en) * | 2012-05-04 | 2014-01-01 | 中国药科大学 | A kind of oral sustained-release preparation, encapsulation material and preparation method |
CN103550830A (en) * | 2013-10-15 | 2014-02-05 | 北京大学 | Alginic acid-hyaluronic acid in situ tissue engineering cell scaffold and its preparation method |
CN104004232A (en) * | 2014-05-07 | 2014-08-27 | 沈阳师范大学 | Biodegradable chitosan-based hydrogel and preparation method thereof |
CN104861178A (en) * | 2015-05-26 | 2015-08-26 | 西北大学 | Pullulan-hyaluronic acid hydrogel and preparation method thereof |
CN105330902A (en) * | 2015-11-20 | 2016-02-17 | 清华大学 | Hyaluronic acid-methyl cellulose composite hydrogel as well as preparation and application thereof |
ES2810013T3 (en) * | 2015-12-29 | 2021-03-08 | Galderma Sa | Carbohydrate crosslinker |
CN106750383B (en) * | 2016-12-20 | 2019-02-12 | 大连理工大学 | Polyethylene glycol hydrogel material and preparation method thereof |
CN106620825B (en) * | 2016-12-26 | 2019-11-12 | 浙江大学 | A two-component rapid hemostatic gel and its application |
CN108192164A (en) * | 2017-12-29 | 2018-06-22 | 安徽天星电缆科技有限公司 | A kind of good torsion cable for robot arm material of thermal stability |
CN110734745B (en) * | 2019-11-28 | 2021-08-17 | 浙江海洋大学 | A kind of cold chain cold storage agent for tuna and preparation method thereof |
CN111019195B (en) * | 2019-12-12 | 2021-12-14 | 武汉纺织大学 | Self-healing hydrogel and preparation method thereof |
CN111978600B (en) * | 2020-09-02 | 2022-07-01 | 山东华熙海御生物医药有限公司 | Hyaluronic acid composite gel for pacifying nipple |
CN112121644B (en) * | 2020-10-19 | 2022-12-06 | 天津工业大学 | Preparation method of oxalic acid cross-linked alginate hydrogel filtering membrane and application of filtering membrane in molecular ion separation |
CN112812330B (en) * | 2021-01-08 | 2022-07-22 | 青岛琛蓝海洋生物工程有限公司 | Compound polysaccharide sodium hyaluronate gel and preparation method thereof |
CN115554276A (en) * | 2021-12-31 | 2023-01-03 | 上海达铸健康科技有限公司 | Joint maintenance patch composition and preparation method thereof |
CN114432234B (en) * | 2022-02-24 | 2024-07-09 | 浦易(上海)生物技术股份有限公司 | Gellable solution combination for obesity intervention and use method and application thereof |
CN116270435A (en) * | 2023-03-27 | 2023-06-23 | 西安交通大学 | Preparation method and application of immune nano-composite hydrogel with anti-tumor effect |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101874904A (en) * | 2009-12-02 | 2010-11-03 | 淄博高新区联创科技服务中心 | Method for preparing medicament-carrying tissue engineering hydrogel |
-
2009
- 2009-11-19 CN CN2009102376051A patent/CN102070786B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101874904A (en) * | 2009-12-02 | 2010-11-03 | 淄博高新区联创科技服务中心 | Method for preparing medicament-carrying tissue engineering hydrogel |
Non-Patent Citations (1)
Title |
---|
JP特开平6-100468A 1994.04.12 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102409731B1 (en) | 2020-04-03 | 2022-06-15 | 한양대학교 산학협력단 | Dual cross-linked self-healing hydrogel |
Also Published As
Publication number | Publication date |
---|---|
CN102070786A (en) | 2011-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102070786B (en) | Hyaluronic acid-sodium alginate composite hydrogel and preparation method thereof | |
Nezhad-Mokhtari et al. | An injectable chitosan-based hydrogel scaffold containing gold nanoparticles for tissue engineering applications | |
US10064889B2 (en) | Mercapto-modified biocompatible macromolecule derivatives with low degree of mercapto-modification and the cross-linked materials and uses thereof | |
Yan et al. | Facile preparation of bioactive silk fibroin/hyaluronic acid hydrogels | |
EP2643029B1 (en) | Preparation and/or formulation of proteins cross-linked with polysaccharides | |
CN109821061B (en) | Adhesive bionic gel with collagen spinning and hyaluronic acid as base materials | |
CN102348464B (en) | Injectable biomaterials | |
CN110408057B (en) | DHPMC blending crosslinking modified collagen suitable for biomedicine and preparation method thereof | |
Li et al. | In vitro and in vivo evaluation of 3D biodegradable thermo/pH sensitive sol-gel reversible hydroxybutyl chitosan hydrogel | |
CN115429935B (en) | Injectable cross-linked chondroitin sulfate hydrogel and preparation method thereof | |
CN110760103B (en) | Viscoelastic hydrogel and preparation method and application thereof | |
CN111471193A (en) | Dialdehyde polysaccharide nanoparticle crosslinked collagen hydrogel and preparation method thereof | |
CN110433327A (en) | A kind of bone renovating material and preparation method thereof | |
CN107854729A (en) | A kind of fibroin albumen base self-healing hydrogel and preparation method thereof | |
CN104548200A (en) | Method of preparing highly branched polysaccharide-fibroin hydrogel bracket | |
CN112999418A (en) | Medical hydrogel composition, medical hydrogel and preparation method thereof | |
CN116687834A (en) | Gel composition containing biphase microspheres and biodegradable high polymer material and application thereof | |
CN114470330A (en) | Recombinant collagen gel particles for tissue filling and preparation method thereof | |
CN110339155A (en) | Thiolated chitosan/gelatin/β-sodium glycerophosphate composite hydrogel and preparation method thereof | |
CN116903884A (en) | A kind of hyaluronic acid-polyglutamic acid hydrogel and preparation method thereof | |
Farrukh et al. | Synthesis and applications of carbohydrate-based hydrogels | |
CN109337098B (en) | Preparation method of enzyme-responsive colon-targeted drug-loaded gel | |
Yuan et al. | Multifunctional thiolated chitosan/puerarin composite hydrogels with pH/glutathione dual responsiveness for potential drug carriers | |
CN108295029A (en) | A kind of injection Multifunctional composite water gel and preparation method thereof | |
Feng et al. | Injectable self-crosslinking hyaluronic acid/silk fibroin blend hydrogel based on disulfide bond |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120530 Termination date: 20131119 |